Yukiharu Matsumoto

Novel Hepatitis C Virus Protease Inhibitors: Thiazolidine Derivatives

Kenji Sudo, Yukiharu Matsumoto, Masaaki Matsushima et al. · Biochemical and Biophysical Research Communications · 1997 · 103 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

A Potent Aldose Reductase Inhibitor, (2<i>S</i>,4<i>S</i>)-6-Fluoro-2‘,5‘-dioxospiro[chroman-4,4‘-imidazolidine]-2-carboxamide (Fidarestat):  Its Absolute Configuration and Interactions with the Aldose Reductase by X-ray Crystallography

Mitsuru Oka, Yukiharu Matsumoto, Shigeru Sugiyama et al. · Journal of Medicinal Chemistry · 2000 · 64 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice

Mizuho Kimura, Yutaka Kawahito, Masahide Hamaguchi et al. · Biomedicine & Pharmacotherapy · 2006 · 24 citations

Medicine, Dermatology, Pharmacology +9

Discovery, Optimization, and Pharmacological Characterization of Novel Heteroaroylphenylureas Antagonists of C−C Chemokine Ligand 2 Function

Edgardo Laborde, Robert W. Macsata, Fanying Meng et al. · Journal of Medicinal Chemistry · 2011 · 23 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity

Katsushi Ijichi, Masatoshi Fujiwara, Hideki Nagano et al. · Antiviral Research · 1996 · 22 citations

Medicine, Medicinal Chemistry, Pharmacology +17